Carbapenem Resistance Of Pseudomonas Aeruginosa: A Review
DOI:
https://doi.org/10.51985/JBUMDC2018108Keywords:
appropriate antibiotics, Carbapenem resistant, transcription of genes.Abstract
Carbapenem resistance towards the gram negative microorganisms especially Pseudomonas aeruginosa is alarming and
on-going public health problem all over the world. It may be intrinsic or acquired through transcription of genes among
microorganisms. These genes are spreading rapidly and are responsible for serious out-breaks. So selection of antibiotics
is limited to treat these resistant cases. Resistant genes are commonly extended in Europe, Asia (Turkey, India, China,
Pakistan and so on) and South America. In Pakistan carbapenem resistance in Pseudomonas aeruginosa isolates is increasing
among hospitalized patients. It shows a progressive trend in multidrug resistance (even towards last resort drug carbapenem).
In this article, we offer an in-depth review of carbapenem resistant Pseudomonas aeruginosa. This will facilitate the readers
to take effective measures in order to control infection and appropriate use of antibiotics.
References
G Meletis, M Exindari, N Vavatsi, D Sofianou, E Diza “Mechanisms responsible for the emergence of carbapenem resistance in pseudomobnas aeruginosa” Hippokrati 2012; 16(4):303-307.
Golle A, Janezic S, Rupnik M. Low overlap between carbapenem resistant Pseudomonas aeruginosa genotypes isolated from hospitalized patients and wastewater treatment plants. PloS one.2017; 12(10):e0186736.
Lin KY, Lauderdale TL, Wang JT, Chang SC. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections. JMI 2016; 49(1):52-9.
Zhang Y, Chen XL, Huang AW, Liu SL, Liu WJ, Zhang N, Lu XZ. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies. ;jEMI 2016; 5(3):e27.
Gonçalves IR, Dantas RC, Ferreira ML, Batistão DW, Gontijo-Filho PP, Ribas RM. Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation. Braz J Microbiol 2017; 48(2):211-7.
Al-Agamy MH, Jeannot K, El-Mahdy TS, Samaha HA, Shibl AM, Plésiat P, Courvalin P. Diversity of molecular mechanisms conferring carbapenem resistance to Pseudomonas aeruginosa isolates from Saudi Arabia, can J infect Dis Med Microbiol. 2016.
Dantas RC, Ferreira ML, Gontijo-Filho PP, Ribas RM. Pseudomonas aeruginosa bacteraemia: sindependent risk factors for mortality and impact of resistance on outcome. jm 2014; 63 (12):1679-87.
Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci, 2017; 6(1):1.
Khan F, Khan A, Kazmi SU. Prevalence and susceptibility pattern of multi drug resistant clinical isolates of Pseudomonas aeruginosa in Karachi. Pak J Med Sci. 2014 Sep; 30 (5):951.
Buehrle DJ, Shields RK, Clarke LG, Potoski BA, Clancy CJ, Nguyen MH. Carbapenem-resistant Psesudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure. Antimicrob agents chemoth. 2017; 61(1):e01243-16.
El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. Eur J Med Chem. 2017; 131:185-95.
Zeng X, Lin J. Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. jFM 2013; 22(4):128.
Jeon JH, Lee JH, Lee JJ, Park KS, Karim AM, Lee CR, Jeong BC, Lee SH. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance. ijms, 2015; 16(5):9654-92.
Chow DC, Rice K, Huang W, Atmar RL, Palzkill T. Engineering specificity from broad to narrow: design of a •-lactamase inhibitory protein (BLIP) variant that exclusively binds and detects KPC •-lactamase. acs, 2016; 2(12):969-79.
Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting effective transitions of care at hospital discharge: a review of key issues. for hospitalists. Journal of hospital medicine: an official publication of the Society of Hospital Medicine. 2007 ;2(5):314-23
Huprikar S, Casner L, Pouch S, Pinheiro Freire M, Madan R, Kwak E, Satlin M, Hartman P, Pisney L, Henrique Mourao P, La Hoz R. Prior Infection or Colonization with Carbapenem-Resistant Enterobacteriaceae Is Not an Absolute Contraindication for Solid Organ Transplantation. In american journal of transplantation. American J Ther. 2016;(16)260.
Dantas RC, e Silva RT, Ferreira ML, Gonçalves IR, Araújo BF, de Campos PA, Royer S, da Fonseca Batistão DW, Gontijo-Filho PP, Ribas RM. Molecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms. PloS one. 2017; 12(5):e0176774.
Bakthavatchalam YD, Anandan S, Veeraraghavan B. Laboratory detection and clinical implication of oxacillinase-48 like carbapenemase: the hidden threat. J Glob Infect Dis, 2016; 8(1):41.
Nakano R, Nakano A, Ishii Y, Ubagai T, Kikuchi-Ueda T, Kikuchi H, Tansho-Nagakawa S, Kamoshida G, Mu X, Ono Y. Rapid detection of the Klebsiella pneumoniae carbapenemase (KPC) gene by loop-mediated isothermal amplification (LAMP). J Intensive Care Med 2015; 21(3):202-6.
Wailan AM, Paterson DL. The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev of Anti-infect ther. 2014; 12(1):91-115.
Labarca JA, Salles MJ, Seas C, Guzmán-Blanco M. Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. Crit Rev Microbiol. 2016; 42(2):276-92.
Ma L, Wang JT, Wu TL, Siu LK, Chuang YC, Lin JC, Lu MC, Lu PL. Emergence of OXA-48-producing Klebsiella pneumoniae in Taiwan. PLoS One. 2015; 10(9):e0139152.
Murray JL, Kwon T, Marcotte EM, Whiteley M. Intrinsic antimicrobial resistance determinants in the superbug Pseudomonas aeruginosa. MBio. 2015; 6(6):e01603-15.
Donkor ES, Newman MJ, Tay SC, Dayie NT, Bannerman E, Olu-Taiwo M. Investigation into the risk of exposure to antibiotic residues contaminating meat and egg in Ghana. Food Control. 2011;22(6):869-73.
Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lon Biol Sci 2015; 370(1670) :20140082
Kuehn BM. “Nightmare” bacteria on the rise in US hospitals, long-term care facilities. Jama. 2013;309(15):1573-4.
Karkey A, Thanh DP, Boinett CJ, Cain AK, Ellington M, Baker KS, Dongol S, Thompson C, Harris SR, Jombart T, Phuong TL. A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of Klebsiella pneumoniae. EMBO molecular medicine 2015; 7(3):227-39.
Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob agents chemother. 2008 ;52(8):2950-4.
Elnour S, Alobied A, Hussain W and Ibrahim M “The blaOXA-48 carbapenem resistant Pseudomoas aeruginosa clinical isolates in Sudan” J Advances in Microbiology 2018; 10(4):1-5;2456-711629.
Giani T, Conte V, Di Pilato V, Aschbacher R, Weber C, Larcher C, Rossolini GM. Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative.J Antimicrob chemother. 2012; 56(4):2211-3.
Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi J Biol Sci, 2018; 25(3):586-96.
Klockgether J, Tümmler B. Recent advances in understanding Pseudomonas aeruginosa as a pathogen. F1000Res 2017; 6:1261.
Van Dijk K, Voets GM, Scharringa J, Voskuil S, Fluit AC, Rottier WC, Leverstein-Van Hall MA, Stuart JC. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. JCMI 2014;20(4):345-9.
Xie J, Yang L, Peters BM, Chen L, Chen D, Li B, Li L, Yu G, Xu Z, Shirtliff ME. A 16-year retrospective surveillance report on the pathogenic features and antimicrobial susceptibility of Pseudomonas aeruginosa isolates from FAHJU in Guangzhou representative of Southern China. Microb pathog. 2017; 110:37-41.
Piedra-Carrasco N, Fàbrega A, Calero-Cáceres W, Cornejo-Sánchez T, Brown-Jaque M, Mir-Cros A, Muniesa M, González-López JJ. Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem. PloS one. 2017; 12(4):e0175246.
Sachdeva R, Sharma B, Sharma R. Evaluation of different phenotypic tests for detection of metallo-•-lactamases in imipenem-resistant Pseudomonas aeruginosa. J lab physicians. 2017; 9(4):249.
Lutgring JD, Limbago BM. The problem of carbapenemase producing carbapenem-resistant Enterobacteriaceae detection. JCM 2016;-02771.
Gupta V, Garg R, Kumaraswamy K, Datta P, Mohi GK, Chander J. Phenotypic and genotypic characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae from blood culture specimens: A study from North India. J Lab Phonol 2018 ;10(2):125.
Pragasam AK, Veeraraghavan B, Bakthavatchalam YD, Gopi R, Aslam RF. Strengths and limitations of various screening methods for carbapenem-resistant Enterobacteriaceae including new method recommended by clinical and laboratory standards institute, 2017: A tertiary care experience. Iran J Microbiol 2017; 35(1):116.
Song W, Hong SG, Yong D, Jeong SH, Kim HS, Kim HS, Kim JS, Bae IK. Combined use of the modified hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-•-lactamase-producing Pseudomonas spp. Sci public policy 2015; 35(2):212-9.
Laolerd W, Akeda Y, Preeyanon L, Ratthawongjirakul P, Santanirand P. Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests. Microb Drug Resist 2018; 24(7): 1006-1011.
Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015; 13(1):42.
Bialvaei AZ, Kafil HS, Asgharzadeh M, Yousef Memar M, Yousefi M. Current methods for the identification of carbapenemases. J Chemother 2016 ;28(1):1-9.
Bedeniæ B, Pleèko V, Sardeliæ S, Uzunoviæ S, Godiè Torkar K. Carbapenemases in gram-negative bacteria: laboratory detection and clinical significance. BioMed res Int 2014; 2014 : 841951.
Mensa J, Barberán J, Soriano A, Llinares P, Marco F, Cantón R, Bou G, del Castillo JG, Maseda E, Ramón Azanza J, Pasquau J. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy. Rev Esp Quimioter. 2018; 31(1).
Fritzenwanker M, Imirzalioglu C, Herold S, Wagenlehner FM, Zimmer KP, Chakraborty T. Treatment options for carbapenem-Resistant Gram negative infections: Dt Sch Arztebl Int 2018;115(20-21): 345-352.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Shaista Bakhat, Yasmeen Taj, Faisal Hanif
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
